Rio Tinto PLC, the world's second-largest mining company, announced that it anticipates its iron-ore shipments from Australian mining operations to exceed expectations for the full year. However, the company has revised its production estimates for several other commodities, including alumina and refined copper. Iron-ore shipments for 2023 are now projected to be in the upper … [Read more...] about Rio Tinto Expects Strong Iron-Ore Shipments in 2023
Ansell: Adapting to Post-Covid Landscape
Australian protective-garment manufacturer, Ansell, is embarking on an organizational overhaul to address the evolving dynamics post-Covid, according to its CEO, Neil Salmon. While the changes come amidst a slowdown in demand that was at its peak during the pandemic, Salmon emphasizes that the restructuring is a response to long-term considerations rather than short-term … [Read more...] about Ansell: Adapting to Post-Covid Landscape
Skandinaviska Enskilda Banken Reports Strong Q2 Results
Skandinaviska Enskilda Banken (SEB), based in Sweden, has announced impressive financial results for the second quarter. The bank's net profit reached 9.77 billion Swedish kronor ($953 million), surpassing expectations and representing a significant increase from SEK5.79 billion in the same period last year. Analysts had predicted a net profit of SEK8.47 billion, according to a … [Read more...] about Skandinaviska Enskilda Banken Reports Strong Q2 Results
SAP Second Quarter Results: Key Details
SAP, the German business-software company, is set to release its second quarter results on Thursday. Here's what you need to know: Revenue Forecast According to a company-provided consensus, SAP is expected to post non-IFRS total revenue of €7.56 billion ($8.50 billion). This forecast represents a 5% year-on-year growth. The cloud revenue is projected to reach €3.40 billion, … [Read more...] about SAP Second Quarter Results: Key Details
First Long-Acting Drug Approved by FDA to Protect Infants and Toddlers from Respiratory Virus
The United States officials have granted approval for the first long-acting drug that offers protection against a respiratory virus that poses a significant threat to babies and toddlers, sending a large number of American children to the hospital every year. Respiratory Syncytial Virus (RSV) is typically a minor inconvenience for most healthy individuals, resembling a common … [Read more...] about First Long-Acting Drug Approved by FDA to Protect Infants and Toddlers from Respiratory Virus
